Neurocircuit Mechanisms of OCD Across the Lifespan

Obsessive-Compulsive Disorder Clinical Trial

Official title:

Neurocircuit Mechanisms of OCD Across the Lifespan

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02437773
• Other study ID #: HUM00091368
• Secondary ID: R01MH102242-01A1
• Status: Completed
• Phase: N/A
• Start date: March 9, 2015
• Est. completion date: October 21, 2020

Study information

• Verified date: November 2020
• Source: University of Michigan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Obsessive-compulsive disorder (OCD), characterized by intrusive thoughts (obsessions) and related behavioral rituals (compulsions), is a common psychiatric illness that often emerges in childhood and causes life-long disability in over 50% of patients. Psychological theory suggests that OCD symptoms are driven by a person's difficulty disengaging their feelings from simple tasks (e.g. washing hands, locking a door) due to excessive anxiety about performance errors. Cognitive behavioral therapy (CBT), the gold standard treatment for OCD, repeatedly exposes patients to their OCD-stressor until this anxiety is reduced. While CBT is typically more effective in teenagers than adults, patients from both age groups are usually left with residual symptoms, highlighting the need for better treatments. In this study, CBT will be studied in both teen-aged and adult patients. Two groups, both with childhood onset OCD, will be randomized to either CBT for OCD or stress management training (SMT), an active therapy but with minimal effects on OCD symptoms. The investigators will also study age-matched, healthy controls as comparison subjects.

Before and after 12 weeks of CBT, all subjects will undergo functional Magnetic Resonance Imaging (fMRI) scans to see what regions of the brain become active when a concentration task is performed and how that activation is changed after CBT. The purpose of this study is to demonstrate the brain changes associated with CBT treatment and how differences in these changes in teenage compared to adult patients may drive differences in CBT response.

Description:

While the study itself is of parallel design for its data-collection and measurement purpose, it is listed as a partial-crossover design in the IRB-approved protocol because subjects randomized to the SMT group are given the option of entering 12-weeks of CBT sessions after all of their SMT data collection. To understand brain changes that occur with CBT compared to SMT in both age groups, the investigators will collect fMRI data before and after therapy. Some limited data will be collected in patients who are initially randomized to SMT but then opt to crossover to CBT. fMRI data will also be collected in healthy teens and adults before and after 12 weeks (but without intervening therapy) to allow the investigators to control for the simple effects of time that may cause brain changes that are not related to therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 206
• Est. completion date: October 21, 2020
• Est. primary completion date: April 13, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 13 Years to 45 Years

Eligibility

Inclusion Criteria for all OCD Subjects & Healthy Volunteers:

• Male or female

• Age 13-17 (inclusive) subjects diagnosed with OCD, age of onset before 15 years

• Age 25-45 (inclusive) subjects diagnosed with OCD, age of onset before 15 years

• Age 13-17 (inclusive) year old healthy volunteers

• Age 25-45 (inclusive) year old healthy volunteers

• OCD adolescent and adult subjects can be on medications but will have to be on a stable medication regimen for at least 4 weeks prior to enrolling.

• Able and willing to give informed consent

• Ability to tolerate small, enclosed spaces without anxiety

Exclusion Criteria for OCD Subjects:

• Anyone between the ages of 18-24 (inclusive range)

• No lifetime diagnosis of bipolar or psychosis disorders

• Age of OCD onset after 15 years old

• No substance/alcohol abuse in the past 6 months

• No lifetime history of substance/alcohol dependence

• No evidence of suicidal intentions or behaviors in the past 6 months

• No history of serious medical or neurological illness

• No history of closed head injury (e.g. loss of consciousness)

• Pregnant or trying to become pregnant

Additional Exclusion Criteria for Healthy Volunteers:

• No history of past or current mental illness

• Not taking any medication, prescription or non-prescription, with psychotropic effects

• First-degree family members with OCD or tic disorders

Related Conditions & MeSH terms

• Obsessive-Compulsive Disorder

Intervention

Behavioral:
• Cognitive Behavioral Therapy - Adolescents
A therapy which gradually yet repeatedly exposes adolescent patients to their obsessive compulsive-relevant "error" cues during a task performance until their anxiety habituates.
• Stress Management Therapy - Adolescents
An active control therapy with minimal effects on OCD symptoms.
• Optional CBT - Adolescents
This is the cross-over element for those that completed the SMT treatment group and opt to have the OCD treatment.
• Cognitive Behavioral Therapy - Adults
A therapy which gradually yet repeatedly exposes adult patients to their obsessive compulsive-relevant "error" cues during a task performance until their anxiety habituates.
• Stress Management Therapy - Adults
An active control therapy with minimal effects on OCD symptoms.
• Optional CBT - Adults
This is the cross-over element for those that completed the SMT treatment group and opt to have the OCD treatment.

Other:
• fMRI only - Healthy Control Adults
Two fMRI's only, scheduled at 12-weeks apart. This is for Healthy Control Adults and is used only as a means for observation, NOT as an intervention to be studied.
• fMRI only - Healthy Control Adolescents
Two fMRI's only, scheduled at 12-weeks apart. This is for Healthy Control Adolescents and is used only as a means for observation, NOT as an intervention to be studied.

Locations

Country	Name	City	State
United States	University of Michigan	Ann Arbor	Michigan

Sponsors (2)

Lead Sponsor	Collaborator
University of Michigan	National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Brain activity as assessed by Magnetic Resonance Imaging (fMRI) scans	fMRI BOLD signal response of posterior medial frontal cortex (pMFC), ventral medial prefrontal cortex (vmPFC) and anterior insula (aIns) during performance monitoring. This signal will be measured as BOLD contrast estimates for errors compared to correct trials based on average signal in a priori defined regions of interest for pMFC, vmPFC and aIns. The investigators are looking for increases in pMFC activation in adolescents from pre- to post-treatment. In contrast, the investigators are looking for increases in inverse connectivity (resting state and during task) between vmPFC and aIns in adults from pre- to post-treatment.	Baseline to 12-weeks
Secondary	OCD symptom severity measured by the Yale Brown Obsessive Compulsive Scale for adults or the Child Yale Brown Obsessive Compulsive Scale for adolescents.	OCD symptom severity measured by the Yale Brown Obsessive Compulsive Scale for adults and the Child Yale Brown Obsessive Compulsive Scale for adolescents. This scale is administered by an independent assessor to rate OCD symptom severity on a scale of 0 to 40, with 40 being most severe. The investigators are looking for decreases in OCD severity ratings from pre- to post-treatment.	Baseline to 12-weeks